Negative regulation of ERK1 and ERK2 cascade

pathway activity — cross-omics
GO:0070373Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of ERK1 and ERK2 cascade pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PAWR, IRAK2, and RAE1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of ERK1 and ERK2 cascade activity versus PAWR in GBM (Pearson r = -0.33).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMPAWR →-0.767-0.556.008.00734
LSCCIRAK2 →+0.551+0.210<.001.00334
LSCCRAE1 →-0.462-0.155.001.00434
LSCCTTC23 →-0.345-0.188<.001<.00134
LUADCEP85L →+0.311+0.143<.001.00134
LSCCKPNA1 →-0.436-0.187<.001.00934
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070373 vs PAWR — GBM

Per-sample scatter of Negative regulation of ERK1 and ERK2 cascade activity vs PAWR in GBM.

Explore this scatter interactively →

Exploration